The purpose of this study is to determine if osteoporosis is an unrecognized complication of
chronic anticoagulation with warfarin.
- Patients on warfarin that have had BMD within a year
- Patients on bisphosphates, SERMS, anticonvulsants, estrogens, androgens, calcitonin,
hctz and thyroid hormone replacement